1185 related articles for article (PubMed ID: 34521385)
21. Predictive Value Analysis of in-Stent Restenosis Within Three Years in Older Acute Coronary Syndrome Patients: A Two-Center Retrospective Study.
Zhou J; Chai D; Dai Y; Wang A; Yan T; Lu S
Clin Appl Thromb Hemost; 2022; 28():10760296221107888. PubMed ID: 35706375
[TBL] [Abstract][Full Text] [Related]
22. A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
Kong S; Chen C; Zheng G; Yao H; Li J; Ye H; Wang X; Qu X; Zhou X; Lu Y; Zhou H
BMC Cardiovasc Disord; 2021 May; 21(1):253. PubMed ID: 34022791
[TBL] [Abstract][Full Text] [Related]
23. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
24. Development, validation and visualization of a web-based nomogram for predicting risk of new-onset diabetes after percutaneous coronary intervention.
Zhu M; Li Y; Wang W; Liu Y; Tong T; Liu Y
Sci Rep; 2024 Jun; 14(1):13652. PubMed ID: 38871809
[TBL] [Abstract][Full Text] [Related]
25. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.
Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F
EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788
[TBL] [Abstract][Full Text] [Related]
26. Predicting the Risk of Unplanned Readmission at 30 Days After PCI: Development and Validation of a New Predictive Nomogram.
Xu W; Tu H; Xiong X; Peng Y; Cheng T
Clin Interv Aging; 2022; 17():1013-1023. PubMed ID: 35818480
[TBL] [Abstract][Full Text] [Related]
27. Development of a novel tool: a nomogram for predicting in-hospital mortality of patients in intensive care unit after percutaneous coronary intervention.
Yuan M; Ren BC; Wang Y; Ren F; Gao D
BMC Anesthesiol; 2023 Jan; 23(1):5. PubMed ID: 36609220
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention.
Ma K; Li J; Shen G; Zheng D; Xuan Y; Lu Y; Li W
Clin Interv Aging; 2022; 17():65-77. PubMed ID: 35115770
[TBL] [Abstract][Full Text] [Related]
29. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
30. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
32. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
[TBL] [Abstract][Full Text] [Related]
33. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of myocardial SPECT to detect in-stent restenosis after drug-eluting stent implantation.
Park HE; Koo BK; Park KW; Paeng JC; Lee HY; Kang HJ; Kim HS
Int J Cardiovasc Imaging; 2012 Dec; 28(8):2125-34. PubMed ID: 22395666
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
36. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
[TBL] [Abstract][Full Text] [Related]
37. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
[TBL] [Abstract][Full Text] [Related]
38. Predictors and variability of drug-eluting vs bare-metal stent selection in contemporary percutaneous coronary intervention: Insights from the PRISM study.
Shafiq A; Gosch K; Amin AP; Ting HH; Spertus JA; Salisbury AC
Clin Cardiol; 2017 Aug; 40(8):521-527. PubMed ID: 28300284
[TBL] [Abstract][Full Text] [Related]
39. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
[TBL] [Abstract][Full Text] [Related]
40. Relationship between left coronary artery bifurcation angle and restenosis after stenting of the proximal left anterior descending artery.
Konishi T; Yamamoto T; Funayama N; Nishihara H; Hotta D
Coron Artery Dis; 2016 Sep; 27(6):449-59. PubMed ID: 27214275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
